Global Fatty Liver Treatment Market Size To Worth USD 35.76 Billion by 2033 | CAGR of 5.19%
Category: HealthcareGlobal Fatty Liver Treatment Market Size To Worth USD 35.76 Billion by 2033
According to a research report published by Spherical Insights & Consulting, the Global Fatty liver treatment Market Size is to Grow from USD 21.55 Billion in 2023 to USD 35.76 Billion by 2033, at a Compound Annual Growth Rate (CAGR) of 5.19% during the projected period.
Get more details on this report -
Browse key industry insights spread across 220 pages with 110 Market data tables and figures & charts from the report on the Global Fatty Liver Treatment Market Size, Share, and COVID-19 Impact Analysis, By Type (Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, and Alcoholic Fatty Liver Disease), By Diagnosis (Imaging, Liver Biopsy, and Blood Tests), By Treatment (Pharmacological Treatment, Surgery, and Lifestyle Changes), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2023 – 2033. Get Detailed Report Description Here: https://www.sphericalinsights.com/reports/fatty-liver-treatment-market
Fatty liver, or hepatic steatosis, is a condition where excess fat accumulates in liver cells, often linked to obesity, high-fat diets, alcohol consumption, or metabolic disorders like diabetes. Two main types are alcoholic fatty liver disease (AFLD) and non-alcoholic fatty liver disease (NAFLD). In early stages, fatty liver is often asymptomatic but may lead to inflammation, scarring (fibrosis), or cirrhosis if untreated. Treatment primarily involves lifestyle changes such as weight loss, a balanced diet, regular exercise, and controlling blood sugar levels. Reducing alcohol intake is crucial for AFLD while managing conditions like diabetes or high cholesterol is key for NAFLD. In severe cases, medications or surgical interventions may be necessary. Early detection improves outcomes. However, a potential drawback of fatty liver treatment is that it often requires a substantial lifestyle change, which can be difficult for many patients to maintain long-term. This includes adopting a strict diet, increasing physical activity, and potentially managing comorbid conditions, all of which can be challenging to implement and sustain over time.
The non-alcoholic steatohepatitis segment is anticipated to hold the greatest share of the global fatty liver treatment market during the projected timeframe.
Based on the type, the global fatty liver treatment market is divided into non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, and alcoholic fatty liver disease. Among these, the non-alcoholic steatohepatitis segment is anticipated to hold the greatest share of the global fatty liver treatment market during the projected timeframe. The non-alcoholic steatohepatitis (NASH) segment is expected to grow in the fatty liver treatment market due to obesity, diabetes, and metabolic syndrome, prompting pharmaceutical companies to develop new therapies.
The imaging segment is anticipated to grow at the fastest pace in the global fatty liver treatment market during the projected timeframe.
Based on the diagnosis, the global fatty liver treatment market is divided into imaging, liver biopsy, and blood tests. Among these, the imaging segment is anticipated to grow at the fastest pace in the global fatty liver treatment market during the projected timeframe. The segment, encompassing non-invasive imaging techniques like ultrasound, MRI, and FibroScan, is expected to grow in the fatty liver treatment market due to its safety, accuracy, and ease of use.
The surgery segment is anticipated to grow at the fastest pace in the global fatty liver treatment market during the projected timeframe.
Based on the treatment, the global fatty liver treatment market is divided into pharmacological treatments, surgery, and lifestyle changes. Among these, the surgery segment is anticipated to grow at the fastest pace in the global fatty liver treatment market during the projected timeframe. Surgical interventions like gastric bypass and sleeve gastrectomy are commonly used to treat NAFLD in obese patients, promoting weight loss, and improving liver fat, inflammation, and fibrosis. Surgical interventions like gastric bypass and sleeve gastrectomy are commonly used to treat NAFLD in obese patients, promoting weight loss, and improving liver fat, inflammation, and fibrosis.
North America is expected to hold the largest share of the global fatty liver treatment market over the forecast period.
Get more details on this report -
North America is expected to hold the largest share of the global fatty liver treatment market over the forecast period. The region is poised to dominate the global fatty liver treatment market due to its advanced healthcare infrastructure, robust research and development activities, and major pharmaceutical companies.
Asia Pacific is predicted to grow at the fastest pace in the global fatty liver treatment market during the projected timeframe. The region’s fatty liver treatment market is expected to experience rapid growth due to rising incidences in China and India, lifestyle changes, obesity, urbanization, improved healthcare infrastructure, and increased liver health awareness.
Major vendors in the Global Fatty Liver Treatment Market include Gilead Sciences, Intercept Pharmaceuticals, Novo Nordisk, Genfit, Echosens, AbbVie, Bristol-Myers Squibb, Merck & Co., Pfizer, Takeda Pharmaceutical Company, Sanofi, Eli Lilly and Company, Amgen, Bayer AG, AstraZeneca, and Others.
Recent Developments
- In January 2023, Researchers at Mount Sinai's Icahn School of Medicine discovered new drug targets for non-alcoholic fatty liver disease using advanced technologies like single-nuclear sequencing and 3D glass imaging.
Key Target Audience
- Market Players
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Value-Added Resellers (VARs)
Market Segment
This study forecasts revenue at global, regional, and country levels from 2020 to 2033. Spherical Insights has segmented the Global Fatty Liver Treatment Market based on the below-mentioned segments:
Global Fatty Liver Treatment Market, By Type
- Non-Alcoholic Fatty Liver Disease
- Non-Alcoholic Steatohepatitis
- Alcoholic Fatty Liver Disease
Global Fatty Liver Treatment Market, By Diagnosis
- Imaging
- Liver Biopsy
- Blood Tests
Global Fatty Liver Treatment Market, By Treatment
- Pharmacological Treatments
- Surgery
- Lifestyle Changes
Global Fatty Liver Treatment Market, Regional
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Australia
- Rest of Asia Pacific
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- South Africa
- Rest of the Middle East & Africa
About the Spherical Insights & Consulting
Spherical Insights & Consulting is a market research and consulting firm which provides actionable market research study, quantitative forecasting and trends analysis provides forward-looking insight especially designed for decision makers and aids ROI.
Which is catering to different industry such as financial sectors, industrial sectors, government organizations, universities, non-profits and corporations. The company's mission is to work with businesses to achieve business objectives and maintain strategic improvements.
CONTACT US:
For More Information on Your Target Market, Please Contact Us Below:
Phone: +1 303 800 4326 (the U.S.)
Phone: +91 90289 24100 (APAC)
Email: inquiry@sphericalinsights.com, sales@sphericalinsights.com
Contact Us: https://www.sphericalinsights.com/contact-us
Need help to buy this report?